6th Annual European Antibody Congress 2010: November 29-December 1, 2010, Geneva, Switzerland.

ABSTRACT: The 6th European Antibody Congress (EAC), organized by Terrapinn Ltd., was held in Geneva, Switzerland, which was also the location of the 4th and 5th EAC. As was the case in 2008 and 2009, the EAC was again the largest antibody congress held in Europe, drawing nearly 250 delegates in 2010. Numerous pharmaceutical and biopharmaceutical companies active in the field of therapeutic antibody development were represented, as were start-up and academic organizations and representatives from the US Food and Drug Administration FDA. The global trends in antibody research and development were discussed, including success stories of recent marketing authorizations of golimumab (Simponi®) and canakinumab (Ilaris®) by Johnson & Johnson and Novartis, respectively, updates on antibodies in late clinica

SUBMITTER: Beck A 

PROVIDER: S-EPMC3092614 | biostudies-literature | 2011 Mar-Apr

REPOSITORIES: biostudies-literature